Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)

Lambers Heerspink HJ., Weldegiorgis M., Inker LA., Gansevoort R., Parving H-H., Dwyer JP., Mondal H., Coresh J., Greene T., Levey AS., de Zeeuw D.

DOI

10.1053/j.ajkd.2013.09.016

Type

Journal article

Journal

American Journal of Kidney Diseases

Publisher

Elsevier BV

Publication Date

02/2014

Volume

63

Pages

244 - 250

Permalink Original publication